| 2026 |
| 09/15 | 3,225 | 3,265 | 3,225 | 3,250 | +0.78% | 35,100 | 1182億6750万 | +0.09% |
| 09/14 | 3,160 | 3,235 | 3,160 | 3,225 | +2.06% | 28,900 | 1173億5775万 | -0.68% |
| 09/11 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 09/11 | 3,140 | 3,170 | 3,135 | 3,160 | -0.47% | 56,700 | 1149億9240万 | -2.65% |
| 09/10 | 3,170 | 3,190 | 3,165 | 3,175 | -0.16% | 33,900 | 1155億3825万 | -2.16% |
| 09/09 | 3,190 | 3,205 | 3,175 | 3,180 | -0.16% | 33,700 | 1157億2020万 | -1.88% |
| 09/08 | 3,200 | 3,225 | 3,175 | 3,185 | -0.62% | 29,600 | 1159億215万 | -1.67% |
| 09/07 | 3,250 | 3,250 | 3,200 | 3,205 | -1.54% | 31,300 | 1166億2995万 | -1.02% |
| 09/04 | 3,280 | 3,285 | 3,245 | 3,255 | -0.91% | 42,200 | 1184億4945万 | +0.62% |
| 09/03 | 3,295 | 3,315 | 3,280 | 3,285 | +0.15% | 33,600 | 1195億4115万 | +1.58% |
| 09/02 | 3,290 | 3,315 | 3,280 | 3,280 | -0.91% | 41,500 | 1193億5920万 | +1.49% |
| 09/01 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 09/01 | 3,285 | 3,325 | 3,280 | 3,310 | +0.91% | 31,400 | 1204億5090万 | +2.51% |
| 08/31 | 3,270 | 3,300 | 3,270 | 3,280 | -0.3% | 87,200 | 1193億5920万 | +1.74% |
| 08/28 | 3,290 | 3,320 | 3,280 | 3,290 | 0% | 40,200 | 1197億2310万 | +2.24% |
| 08/27 | 3,335 | 3,335 | 3,280 | 3,290 | -1.35% | 35,400 | 1197億2310万 | +2.46% |
| 08/26 | 3,305 | 3,340 | 3,300 | 3,335 | +0.76% | 38,700 | 1213億6065万 | +4.06% |
| 08/25 | 3,265 | 3,315 | 3,265 | 3,310 | +1.38% | 52,000 | 1204億5090万 | +3.53% |
| 08/24 | 3,285 | 3,305 | 3,260 | 3,265 | +0.15% | 35,000 | 1188億1335万 | +2.38% |
| 08/21 | 3,280 | 3,285 | 3,250 | 3,260 | -0.61% | 43,700 | 1186億3140万 | +2.42% |
| 08/20 | 3,240 | 3,280 | 3,230 | 3,280 | +1.86% | 58,900 | 1193億5920万 | +3.21% |
| 08/19 | （IR情報）16:00 トピロリック錠の製造販売承認の承継および資産譲受のお知らせ |
| 08/19 | 3,225 | 3,235 | 3,190 | 3,220 | 0% | 42,500 | 1171億7580万 | +1.51% |
| 08/18 | 3,190 | 3,240 | 3,190 | 3,220 | +0.78% | 35,800 | 1171億7580万 | +1.67% |
| 08/17 | 3,255 | 3,255 | 3,180 | 3,195 | -1.69% | 42,500 | 1162億6605万 | +0.98% |
| 08/14 | 3,240 | 3,260 | 3,230 | 3,250 | 0% | 40,400 | 1182億6750万 | +2.82% |
| 08/13 | 3,225 | 3,250 | 3,215 | 3,250 | +0.78% | 33,400 | 1182億6750万 | +2.91% |
| 08/12 | 3,250 | 3,250 | 3,215 | 3,225 | -0.46% | 38,900 | 1173億5775万 | +2.25% |
| 08/10 | 3,230 | 3,250 | 3,205 | 3,240 | +0.93% | 38,700 | 1179億360万 | +2.79% |
| 08/07 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 08/07 | 3,135 | 3,230 | 3,125 | 3,210 | +2.39% | 68,900 | 1168億1190万 | +1.97% |
| 08/06 | 3,100 | 3,150 | 3,090 | 3,135 | +2.12% | 89,100 | 1140億8265万 | -0.35% |
| 08/05 | 3,145 | 3,150 | 3,070 | 3,070 | -1.6% | 93,300 | 1117億1730万 | -2.45% |
| 08/04 | 3,175 | 3,175 | 3,090 | 3,120 | -1.89% | 128,000 | 1135億3680万 | -1.02% |
| 08/03 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 08/03 | （IR情報）14:00 2027年3月期第1四半期決算短信〔日本基準〕(連結) |
| 08/03 | 3,170 | 3,245 | 3,075 | 3,180 | +1.92% | 143,900 | 1157億2020万 | +0.79% |
| 07/31 | 3,240 | 3,245 | 3,120 | 3,120 | -3.41% | 68,900 | 1135億3680万 | -1.05% |
| 07/30 | 3,245 | 3,255 | 3,180 | 3,230 | -0.46% | 66,200 | 1175億3970万 | +2.41% |
| 07/29 | 3,195 | 3,270 | 3,175 | 3,245 | +1.88% | 71,600 | 1180億8555万 | +2.89% |
| 07/28 | 3,190 | 3,200 | 3,160 | 3,185 | -0.31% | 51,600 | 1159億215万 | +1.08% |
| 07/27 | 3,155 | 3,200 | 3,145 | 3,195 | +2.4% | 66,300 | 1162億6605万 | +1.49% |
| 07/24 | 3,120 | 3,135 | 3,105 | 3,120 | 0% | 44,900 | 1135億3680万 | -0.86% |
| 07/23 | 3,140 | 3,140 | 3,105 | 3,120 | -0.64% | 65,200 | 1135億3680万 | -0.92% |
| 07/22 | 3,145 | 3,165 | 3,125 | 3,140 | -0.16% | 58,700 | 1142億6460万 | -0.25% |
| 07/21 | 3,135 | 3,170 | 3,115 | 3,145 | +0.96% | 66,800 | 1144億4655万 | -0.1% |
| 07/17 | 3,120 | 3,145 | 3,100 | 3,115 | +0.16% | 51,600 | 1133億5485万 | -1.05% |
| 07/16 | 3,155 | 3,175 | 3,110 | 3,110 | -0.96% | 53,800 | 1131億7290万 | -1.3% |
| 07/15 | 3,130 | 3,155 | 3,120 | 3,140 | +0.8% | 52,900 | 1142億6460万 | -0.48% |
| 07/14 | 3,130 | 3,150 | 3,110 | 3,115 | +0.16% | 54,200 | 1133億5485万 | -1.33% |
| 07/13 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 07/13 | 3,155 | 3,155 | 3,110 | 3,110 | -0.8% | 62,300 | 1131億7290万 | -1.61% |
| 07/10 | 3,160 | 3,160 | 3,130 | 3,135 | +0.16% | 49,100 | 1140億8265万 | -0.92% |
| 07/09 | 3,165 | 3,165 | 3,130 | 3,130 | -0.79% | 45,900 | 1139億70万 | -1.14% |
| 07/08 | 3,170 | 3,185 | 3,155 | 3,155 | 0% | 70,600 | 1148億1045万 | -0.38% |
| 07/07 | 3,175 | 3,195 | 3,130 | 3,155 | -0.47% | 163,500 | 1148億1045万 | -0.38% |
| 07/06 | 3,185 | 3,210 | 3,160 | 3,170 | +0.63% | 59,900 | 1153億5630万 | +0.03% |
| 07/03 | 3,200 | 3,245 | 3,150 | 3,150 | -0.47% | 51,400 | 1146億2850万 | -0.85% |
| 07/02 | 3,210 | 3,220 | 3,165 | 3,165 | +0.16% | 47,100 | 1151億7435万 | -0.75% |
| 07/01 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 07/01 | （IR情報）14:00 痛風・高尿酸血症治療剤「ユリス錠」の小児に対する用法・用量追加の承認事項一部変更承認申請のお知らせ |
| 07/01 | 3,175 | 3,190 | 3,155 | 3,160 | -0.94% | 49,400 | 1149億9240万 | -1.22% |
| 06/30 | 3,195 | 3,220 | 3,180 | 3,190 | -0.16% | 66,000 | 1160億8410万 | -0.65% |
| 06/29 | 3,175 | 3,220 | 3,165 | 3,195 | +1.91% | 63,900 | 1162億6605万 | -0.9% |
| 06/26 | 3,165 | 3,170 | 3,135 | 3,135 | -0.16% | 54,900 | 1140億8265万 | -3.15% |
| 06/25 | 3,225 | 3,235 | 3,140 | 3,140 | -2.94% | 65,700 | 1142億6460万 | -3.62% |
| 06/24 | 3,180 | 3,260 | 3,180 | 3,235 | +2.54% | 52,700 | 1177億2165万 | -1.31% |
| 06/23 | 3,115 | 3,175 | 3,105 | 3,155 | +0.8% | 46,400 | 1148億1045万 | -4.13% |
| 06/22 | 3,135 | 3,165 | 3,120 | 3,130 | -0.63% | 42,700 | 1139億70万 | -5.32% |
| 06/19 | 3,170 | 3,175 | 3,125 | 3,150 | -0.79% | 86,100 | 1146億2850万 | -5.12% |
| 06/18 | 3,140 | 3,190 | 3,105 | 3,175 | +2.09% | 66,300 | 1155億3825万 | -4.68% |
| 06/17 | 3,125 | 3,145 | 3,095 | 3,110 | -0.48% | 74,100 | 1131億7290万 | -6.8% |
| 06/16 | 3,140 | 3,145 | 3,095 | 3,125 | -0.79% | 48,900 | 1137億1875万 | -6.66% |
| 06/15 | 3,230 | 3,240 | 3,150 | 3,150 | -1.56% | 43,000 | 1146億2850万 | -6.22% |
| 06/12 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 06/12 | 3,190 | 3,205 | 3,175 | 3,200 | +0.16% | 48,300 | 1164億4800万 | -5.07% |
| 06/11 | 3,215 | 3,215 | 3,130 | 3,195 | +0.16% | 42,000 | 1162億6605万 | -5.45% |
| 06/10 | 3,215 | 3,250 | 3,175 | 3,190 | -0.78% | 40,900 | 1160億8410万 | -5.84% |
| 06/09 | 3,205 | 3,225 | 3,195 | 3,215 | +0.47% | 40,300 | 1169億9385万 | -5.3% |
| 06/08 | 3,185 | 3,240 | 3,175 | 3,200 | +0.63% | 56,000 | 1164億4800万 | -5.91% |
| 06/05 | 3,195 | 3,220 | 3,180 | 3,180 | +1.11% | 39,500 | 1157億2020万 | -6.66% |
| 06/04 | 3,150 | 3,180 | 3,120 | 3,145 | -0.32% | 61,500 | 1144億4655万 | -7.88% |
| 06/03 | 3,205 | 3,205 | 3,130 | 3,155 | -1.71% | 53,400 | 1148億1045万 | -7.86% |
| 06/02 | 3,325 | 3,325 | 3,210 | 3,210 | -4.61% | 57,100 | 1168億1190万 | -6.55% |
| 06/01 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 06/01 | 3,425 | 3,440 | 3,325 | 3,365 | -2.46% | 75,500 | 1224億5235万 | -2.24% |
| 05/29 | 3,415 | 3,450 | 3,395 | 3,450 | +1.02% | 139,300 | 1255億4550万 | +0.06% |
| 05/28 | 3,475 | 3,480 | 3,390 | 3,415 | -1.73% | 79,000 | 1242億7185万 | -1.1% |
| 05/27 | 3,460 | 3,495 | 3,395 | 3,475 | -0.57% | 70,900 | 1264億5525万 | +0.43% |
| 05/26 | 3,540 | 3,555 | 3,485 | 3,495 | -1.27% | 96,100 | 1271億8305万 | +0.84% |
| 05/25 | 3,655 | 3,665 | 3,510 | 3,540 | -3.15% | 91,300 | 1288億2060万 | +1.96% |
| 05/22 | 3,670 | 3,670 | 3,595 | 3,655 | +0.27% | 58,200 | 1330億545万 | +5.36% |
| 05/21 | 3,600 | 3,670 | 3,600 | 3,645 | +2.68% | 93,000 | 1326億4155万 | +5.23% |
| 05/20 | 3,565 | 3,600 | 3,510 | 3,550 | +0.42% | 83,800 | 1291億8450万 | +2.69% |
| 05/19 | 3,530 | 3,560 | 3,490 | 3,535 | +1.43% | 76,400 | 1286億3865万 | +2.32% |
| 05/18 | 3,345 | 3,550 | 3,325 | 3,485 | +2.05% | 151,900 | 1268億1915万 | +0.87% |
| 05/15 | （IR情報）14:00 役員の異動に関するお知らせ |
| 05/15 | （IR情報）14:00 2026年3月期決算短信〔日本基準〕(連結) |
| 05/15 | （IR情報）14:00 子会社の人事異動のお知らせ |
| 05/15 | （IR情報）14:00 人事異動のお知らせ |
| 05/15 | 3,330 | 3,450 | 3,315 | 3,415 | +2.4% | 136,500 | 1242億7185万 | -1.1% |
| 05/14 | 3,340 | 3,365 | 3,310 | 3,335 | -1.33% | 43,000 | 1213億6065万 | -3.45% |
| 05/13 | 3,395 | 3,410 | 3,360 | 3,380 | -0.44% | 39,500 | 1229億9820万 | -2.34% |
| 05/12 | 3,400 | 3,455 | 3,380 | 3,395 | -1.31% | 90,200 | 1235億4405万 | -2.13% |
| 05/11 | 3,400 | 3,465 | 3,400 | 3,440 | +1.03% | 73,000 | 1251億8160万 | -1.09% |
| 05/08 | 3,430 | 3,430 | 3,385 | 3,405 | -0.73% | 80,200 | 1239億795万 | -2.1% |
| 05/07 | 3,370 | 3,445 | 3,340 | 3,430 | +1.93% | 92,200 | 1248億1770万 | -1.61% |
| 05/01 | 3,345 | 3,365 | 3,310 | 3,365 | 0% | 56,900 | 1224億5235万 | -3.77% |
| 04/30 | （IR情報）14:00 肺動脈性肺高血圧症および間質性肺疾患に伴う肺高血圧症治療剤MD-712（吸入粉末剤）の日本における製造販売承認申請のお知らせ |
| 04/30 | 3,310 | 3,375 | 3,295 | 3,365 | +0.45% | 86,500 | 1224億5235万 | -4.1% |
| 04/28 | 3,310 | 3,350 | 3,305 | 3,350 | +0.15% | 58,200 | 1219億650万 | -4.88% |
| 04/27 | 3,350 | 3,355 | 3,305 | 3,345 | -1.33% | 65,500 | 1217億2455万 | -5.27% |
| 04/24 | 3,430 | 3,445 | 3,375 | 3,390 | -1.17% | 45,200 | 1233億6210万 | -4.16% |
| 04/23 | 3,425 | 3,430 | 3,375 | 3,430 | +0.73% | 96,400 | 1248億1770万 | -3.22% |
| 04/22 | 3,475 | 3,490 | 3,390 | 3,405 | -2.99% | 91,100 | 1239億795万 | -4.11% |
| 04/21 | 3,590 | 3,590 | 3,490 | 3,510 | -1.68% | 88,500 | 1277億2890万 | -1.32% |
| 04/16 | （IR情報）10:00 「オンボー皮下注200mgオートインジェクター/シリンジ」の既存治療で効果不十分な中等症から重症の潰瘍性大腸炎の維持療法に対する適応追加承認を取得 |
| 04/15 | （IR情報）14:00 ホリトロピンアルファのバイオシミラーに関する提携契約締結のお知らせ |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
